Nurse Practitioner, Adult Health · New Haven, CT
NPI
1750650149
Since 2011
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
20 York St
New Haven, CT, 06510
Phone (203) 200-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
234 services
Medicare patients, 2024
82
Average age 74
Drug cost, 2024
$5.3M
1,089 prescriptions
Company payments, 2024
$98.33
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily A Duffield was code 99214 (office e&m - established), 188 times for 71 patients. In total Emily A Duffield billed 234 services in 6 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 188 | 71 | $65.63 | $12K |
| 99215 Office E&M - Established | Office | 32 | 23 | $100.16 | $3,205 |
By year: 2022 $21K for 283 services; 2023 $20K for 283 services; 2024 $16K for 234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emily A Duffield prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 143 prescriptions and refills. In total Emily A Duffield wrote 1,089 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 143 | 145 | 26 | $2.3M |
| Eliquis Apixaban | 65 | 93 | 18 | $55K |
| Dexamethasone Generic | 60 | 64 | 39 | $1,216 |
| Oxycodone Hcl Generic | 53 | 53 | 23 | $1,043 |
| Lorazepam Generic | 49 | 49 | 20 | $175 |
| Prochlorperazine Maleate Generic | 48 | 48 | 36 | $672 |
| Alunbrig Brigatinib | 42 | 42 | Under 11 | $714K |
| Levothyroxine Sodium Generic | 40 | 78 | 14 | $333 |
| Alprazolam Generic | 28 | 28 | Under 11 | $61.14 |
| Lorbrena Lorlatinib | 18 | 18 | Under 11 | $384K |
| Gilotrif Afatinib Dimaleate | 16 | 16 | Under 11 | $165K |
| Alecensa Alectinib Hcl | 15 | 20 | Under 11 | $277K |
| Prednisone Generic | 15 | 17 | 11 | $79.9 |
| Pregabalin Generic | 14 | 14 | Under 11 | $151 |
| Ondansetron Hcl Generic | 14 | 16 | 11 | $482 |
Brand drugs: - claims; generic drugs: 640 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Emily A Duffield $98.33 ($98.33 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Scientific Affairs, LLC with $77.5.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.